MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 287 filers reported holding MYRIAD GENETICS INC in Q1 2014. The put-call ratio across all filers is 2.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $12,200,000 | -63.8% | 592,800 | -46.2% | 0.00% | -66.7% |
| Q2 2016 | $33,743,000 | -30.8% | 1,102,721 | -15.4% | 0.01% | -30.8% |
| Q1 2016 | $48,761,000 | -83.0% | 1,302,721 | -80.4% | 0.01% | -83.8% |
| Q4 2015 | $287,447,000 | -12.9% | 6,660,038 | -24.4% | 0.08% | -17.5% |
| Q3 2015 | $330,131,000 | +8.6% | 8,808,185 | -1.5% | 0.10% | +18.3% |
| Q2 2015 | $303,871,000 | -4.0% | 8,940,000 | 0.0% | 0.08% | -3.5% |
| Q1 2015 | $316,476,000 | +3.9% | 8,940,000 | 0.0% | 0.08% | +2.4% |
| Q4 2014 | $304,496,000 | +3.1% | 8,940,000 | +16.8% | 0.08% | 0.0% |
| Q3 2014 | $295,258,000 | +43.3% | 7,655,115 | +44.6% | 0.08% | +45.6% |
| Q2 2014 | $206,084,000 | +88.7% | 5,295,079 | +65.7% | 0.06% | +83.9% |
| Q1 2014 | $109,237,000 | – | 3,195,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 6,635,000 | $106,425 | 3.51% |
| Glenview Capital Management | 3,783,982 | $60,695,071 | 1.37% |
| AMH Equity Ltd | 47,285 | $758,451 | 0.83% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,973,312 | $31,651,924 | 0.75% |
| EARNEST PARTNERS LLC | 3,473,281 | $55,711,427 | 0.32% |
| AIMZ Investment Advisors, LLC | 40,985 | $657,399 | 0.29% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 280,767 | $4,503,503 | 0.13% |
| Beverly Hills Private Wealth, LLC | 19,687 | $315,779 | 0.09% |
| Artisan Partners Limited Partnership | 2,537,147 | $40,695,838 | 0.07% |
| Jump Financial, LLC | 84,924 | $1,362,181 | 0.05% |